BHVN

Latest SEC Filings & News for BHVN

2 most recent filings and news items mentioning BHVN. Updated every 60 seconds.

Get this data via API — free tier: 10,000 calls/day

curl "https://api.brieftape.com/v1/tickers/BHVN/news?limit=20"

Pull BHVN filings straight into your trading bot, model, or app.

Get an API key — free tier: 10,000 calls/day

LeadershipJul 9, 2026Positive

Biohaven names Dr. Pirman as new Head of Discovery.

Biohaven promoted Dr. David Pirman to Executive Vice President and Head of Discovery, while Bruce Car transitioned to Chief Innovation Officer. This leadership shift aims to accelerate drug innovation and external collaborations.

View filing at SEC.gov →

RegulatoryMay 27, 2026Positive

Biohaven reports opakalim shows 3-fold seizure control improvement in epilepsy trial

Biohaven presented clinical data showing opakalim, a Kv7.2/7.3 activator, achieved a 3-fold prolongation in time to seizure occurrence in idiopathic generalized epilepsy and 54% seizure reduction in focal epilepsy patients with a favorable tolerability profile. The positive inter

View filing at SEC.gov →

AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.